Erasca, Inc. (ERAS)
NASDAQ: ERAS · Real-Time Price · USD
1.900
+0.050 (2.70%)
Jan 21, 2025, 4:00 PM EST - Market closed
Erasca Employees
Erasca had 126 employees as of December 31, 2023. The number of employees decreased by 3 or -2.33% compared to the previous year.
Employees
126
Change (1Y)
-3
Growth (1Y)
-2.33%
Revenue / Employee
n/a
Profits / Employee
-$1,262,849
Market Cap
537.18M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 126 | -3 | -2.33% |
| Dec 31, 2022 | 129 | 6 | 4.88% |
| Dec 31, 2021 | 123 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
ERAS News
- 2 months ago - Erasca Reports Third Quarter 2024 Business Updates and Financial Results - GlobeNewsWire
- 2 months ago - Erasca to Present at Upcoming Investor Conferences - GlobeNewsWire
- 5 months ago - Erasca Reports Second Quarter 2024 Business Updates and Financial Results - GlobeNewsWire
- 8 months ago - Erasca to Present at Upcoming Investor Conferences in June - GlobeNewsWire
- 8 months ago - Erasca Announces Closing of Underwritten Offering of Common Stock and Full Exercise of the Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 8 months ago - Erasca Announces Strategic In-Licensing of RAS-Targeting Franchise - GlobeNewsWire
- 8 months ago - Erasca Announces Pricing of Underwritten Offering of Common Stock - GlobeNewsWire
- 9 months ago - Erasca Reports First Quarter 2024 Business Updates and Financial Results - GlobeNewsWire